ARTICLE | Company News
Oxford BioMedica deal
October 31, 2005 8:00 AM UTC
OXB said it granted an undisclosed company a license to LentiVector gene delivery technology for research activities. OXB said it will receive an upfront payment and an annual maintenance fee. ...